nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Pentazocine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Pentazocine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Pentazocine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Pentazocine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Pentazocine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Pentazocine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Pentazocine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Pentazocine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Pentazocine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Pentazocine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Pentazocine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Pentazocine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Pentazocine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Pentazocine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Pentazocine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Pentazocine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Pentazocine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Pentazocine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Pentazocine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Pentazocine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Pentazocine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Pentazocine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Pentazocine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Pentazocine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Pentazocine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Pentazocine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Pentazocine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Pentazocine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Pentazocine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Pentazocine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Pentazocine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Pentazocine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Pentazocine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Pentazocine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Pentazocine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Pentazocine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Pentazocine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Pentazocine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Pentazocine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Pentazocine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Pentazocine—Chills—Etoposide—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Pentazocine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Pentazocine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Pentazocine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Pentazocine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Pentazocine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Pentazocine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Pentazocine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Pentazocine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Pentazocine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Pentazocine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Pentazocine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Pentazocine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Pentazocine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Pentazocine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Pentazocine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Pentazocine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Pentazocine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Pentazocine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Pentazocine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Pentazocine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Pentazocine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Pentazocine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Pentazocine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Pentazocine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Pentazocine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Pentazocine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Pentazocine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Pentazocine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Pentazocine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Pentazocine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Pentazocine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Pentazocine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Pentazocine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Pentazocine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Pentazocine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Pentazocine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Pentazocine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Pentazocine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Pentazocine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Pentazocine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Pentazocine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Pentazocine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Pentazocine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Pentazocine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Pentazocine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Pentazocine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Pentazocine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Pentazocine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Pentazocine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Pentazocine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Pentazocine—Headache—Topotecan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Pentazocine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Pentazocine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Pentazocine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Pentazocine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Pentazocine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Pentazocine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Pentazocine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Pentazocine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Pentazocine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Pentazocine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Pentazocine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Pentazocine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Pentazocine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Pentazocine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Pentazocine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Pentazocine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Pentazocine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Pentazocine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Pentazocine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Pentazocine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Pentazocine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Pentazocine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Pentazocine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Pentazocine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Pentazocine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Pentazocine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Pentazocine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Pentazocine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Pentazocine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Pentazocine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Pentazocine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Pentazocine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Pentazocine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Pentazocine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Pentazocine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Pentazocine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Pentazocine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Pentazocine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Pentazocine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Pentazocine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Pentazocine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Pentazocine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Pentazocine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Pentazocine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Pentazocine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Pentazocine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Pentazocine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Pentazocine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Pentazocine—Headache—Vincristine—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Pentazocine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Pentazocine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Pentazocine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Pentazocine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Pentazocine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Pentazocine—Chills—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Pentazocine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Pentazocine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Pentazocine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Pentazocine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Pentazocine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Pentazocine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Pentazocine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Pentazocine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Pentazocine—Headache—Etoposide—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Pentazocine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Pentazocine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Pentazocine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Pentazocine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000983	0.000983	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.000958	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000944	0.000944	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000939	0.000939	CcSEcCtD
Pentazocine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000929	0.000929	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000909	0.000909	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000903	0.000903	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000894	0.000894	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.000874	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000828	0.000828	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000779	0.000779	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000691	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000688	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Pentazocine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000665	0.000665	CcSEcCtD
Pentazocine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000645	0.000645	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000633	CcSEcCtD
Pentazocine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
